Psychopharmacology

, Volume 169, Issue 3–4, pp 383–389 | Cite as

Source monitoring improvement in patients with schizophrenia receiving antipsychotic medications

  • Richard S. E. Keefe
  • Margaret P. Poe
  • Joseph P. McEvoy
  • Adam Vaughan
Original Investigation

Abstract

Rationale

The absence of a relationship between cognitive deficit treatment response and positive symptom treatment response is often assumed, and few data have shed light on this issue. Most of these data have been collected using standard neuropsychological measures, which are ill-designed to assess the types of neurocognitive disturbances associated with psychotic symptoms. This study investigates the effect of treatment on source monitoring performance and its relation to the reduction of certain psychotic symptoms associated with the inability to identify self-generated mental events, known as "autonoetic agnosia".

Objectives

To determine whether risperidone, olanzapine, and haloperidol were differentially effective in reducing autonoetic agnosia and whether changes in this aspect of cognition were related to reduction of specific symptoms of psychosis.

Methods

From a cohort of 49 patients diagnosed with schizophrenia by DSM-IV criteria and randomly assigned to double-blind treatment with risperidone, olanzapine, or haloperidol, 16 patients were identified with symptoms believed to reflect autonoetic agnosia ("target symptoms") as assessed with the Schneiderian Symptom Rating Scale, and then evaluated during a baseline period, and then at 1, 2, and 3 weeks. Autonoetic agnosia was assessed as the ability of a patient to distinguish self-generated words from both experimenter-generated words and pictorially presented words.

Results

Analysis of patients from all treatment groups found a significant reduction in the number of "target" Schneiderian symptoms. Discrimination for items from the self-generated and heard sources significantly improved with treatment, as did the number of self-generated items that patients remembered as coming from the heard source ("self-hear errors"). The correlation between improvement in recognition of self-generated items and reduction in target Schneiderian symptoms after 2 weeks of treatment suggested a modest relationship between symptom improvement and changes in autonoetic agnosia.

Conclusions

While the differences between medications were not statistically significant, antipsychotic medication in general was associated with improvements in symptoms and cognitive deficits that may underlie autonoetic agnosia. Improvement of autonoetic agnosia was a weak predictor of positive symptom improvement in a limited sample.

Keywords

Source monitoring Autonoetic agnosia Schizophrenia Cognitive deficits Positive symptoms Treatment 

Notes

Acknowledgements

This research was supported by grants to Dr. Keefe from the National Alliance for Research in Schizophrenia and Depression (NARSAD) and the Janssen Research Foundation.

References

  1. Addington J, Addington D, Maticka-Tyndale E (1991) Cognitive functioning and positive and negative symptoms in schizophrenia. Schizophr Res 4:123–134CrossRefGoogle Scholar
  2. Amador XF, Strauss DH, Yale SA, Gorman JM (1991) Awareness of illness in schizophrenia. Schizophr Bull 17:113–132PubMedGoogle Scholar
  3. Battig WF, Montague WE (1969) Category norms for verbal items in 56 categories: a replication and extension of the Connecticut category norms. J Exp Psychol Monogr 80:1–46Google Scholar
  4. Bentall RP, Baker GA, Havers S (1991) Reality monitoring and psychotic hallucinations. Br J Clin Psychol 30:213–222PubMedGoogle Scholar
  5. Braff DL, Heaton R, Kuck J Cullum M, Moranville J, Grant I, Ziscook S (1991) The generalized pattern of neuropsychological deficits in outpatients with chronic schizophrenia with heterogeneous Wisconsin Card Sorting Test results. Arch Gen Psychiatry 48:891–898PubMedGoogle Scholar
  6. Cuesta MJ, Peralta V (1995) Cognitive disorders in the positive, negative and disorganization syndromes of schizophrenia. Psychiatry Res 58:227–235CrossRefPubMedGoogle Scholar
  7. Davidson M, Keefe RSE (1995) Cognitive impairment as a target for pharmacological treatment in schizophrenia. Schizophr Res 17:123–129PubMedGoogle Scholar
  8. Dixon MJ, King S (1995) The concordance between symptom information gathered from remitted schizophrenic patients and their relatives. J Psychiatr Res 29:447–456CrossRefPubMedGoogle Scholar
  9. Frith CD (1992) The cognitive neuropsychology of schizophrenia. Erlbaum, Hove, UKGoogle Scholar
  10. Frith CD, Done DJ (1989) Experiences of alien control in schizophrenia reflect a disorder in the central monitoring of action. Psychol Med 19:359–363PubMedGoogle Scholar
  11. Gold JM, Harvey PD (1993) Cognitive deficits in schizophrenia. Psychiatr Clin N Am 16:295–312Google Scholar
  12. Goldberg TE, Gold JM, Greenberg R, Griffin S, Schulz SC, Pickar D, Kleinman JE, Weinberger DR (1993) Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery. Am J Psychiatry 150:1355–1362PubMedGoogle Scholar
  13. Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153:321–330Google Scholar
  14. Green MF, Marder SR, Glynn SM, McGurk SR, Wirshing WC, Wirshing DA, Liberman RP, Mintz J (2002) The neurocognitive effects of low-dose haloperidol: A two-year comparison with risperidone. Biol Psychiatry 51:972–978CrossRefPubMedGoogle Scholar
  15. Harvey PD, Keefe RSE (1997) Cognitive impairment in schizophrenia and implications of atypical neuroleptic treatment. CNS Spectrums 2:1–11Google Scholar
  16. Harvey PD, Keefe RSE (2001) Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. Am J Psychiatry 158:176–184PubMedGoogle Scholar
  17. Hashtroudi S, Johnson MK, Chrosniak LD (1989) Aging and source monitoring. Psychol Aging 4:106–112CrossRefPubMedGoogle Scholar
  18. Hirshman E, Bjork RA (1988) The generation effect: support for a two-factor theory. J Exp Psychol [Learn Mem Cognit] 14:484–494Google Scholar
  19. Johnson MK, Raye CL (1981) Reality monitoring. Psychol Rev 88:67–85CrossRefGoogle Scholar
  20. Johnson MK, Hashtroudi S, Lindsay DS (1993) Source monitoring. Psychol Bull 114:3–28CrossRefPubMedGoogle Scholar
  21. Keefe RSE (1998) The neurobiology of disturbances of the self: Autonoetic agnosia in schizophrenia. In: Amador XF, David A (eds) Insight and psychosis. Oxford University Press, New York, pp 142–173Google Scholar
  22. Keefe RSE, Mohs RC, Losonczy MF, Davidson M, Silverman JM, Kendler KS, Nora R, Horvath TB, Davis KL (1987) Characteristics of very poor outcome schizophrenia. Am J Psychiatry 144:889–895PubMedGoogle Scholar
  23. Keefe RSE, Arnold MC, Bayen UJ, Harvey P (1999a) Source monitoring deficits in patients with schizophrenia: a multinomial modeling analysis. Psychol Med 29:903–914CrossRefPubMedGoogle Scholar
  24. Keefe RSE, Silva SG, Perkins DO, Lieberman JA (1999b) The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophr Bull 25:201–222PubMedGoogle Scholar
  25. Keefe RSE et al. (2000) Treatment of neurocognitive deficits with olanzapine or haloperidol in first episode psychosis. Presented at the Annual Meeting of the American College of Neuropsychopharmacology, San Juan, DecemberGoogle Scholar
  26. Keefe RSE, Arnold MC, Bayen UJ, McEvoy JP, Wilson WH (2002) Source monitoring deficits for self-generated stimuli in schizophrenia: multinomial modeling of data from three sources. Schizophr Res 57:51–67CrossRefPubMedGoogle Scholar
  27. Manschreck TC, Maher BA, Waller NG, Ames D, Latham CA (1985) Deficient motor synchrony in schizophrenic disorders: clinical correlates. Biol Psychiatry 20:990–1002PubMedGoogle Scholar
  28. Mlakar J, Jensterle J, Frith CD (1994) Central monitoring deficiency and schizophrenia symptoms. Psychol Med 24:557–564PubMedGoogle Scholar
  29. Morris RG, Rushe T, Woodruffe PW, Murray RM (1995) Problem solving in schizophrenia: a specific deficit in planning ability. Schizophr Res 14:235–246CrossRefPubMedGoogle Scholar
  30. Perlick D, Mattis S, Stastny P, Silverstein B (1992) Negative symptoms are related to both frontal and nonfrontal neuropsychological measures in chronic schizophrenia. Arch Gen Psychiatry 49:245–246PubMedGoogle Scholar
  31. Riefer DM, Rouder JN (1991) A multinomial modeling analysis of the mnemonic benefits of bizarre imaging. Mem Cognit 20:601–611Google Scholar
  32. Schneider K (1959) Klinische Psychopathologie, 5th edn. Grune and Stratton, New YorkGoogle Scholar
  33. Slamecka NJ, Graf P (1978) The generation effect: delineation of a phenomenon. J Exp Psychol [Hum Learn Mem] 4:592–604Google Scholar
  34. Stirling JD, Hellewell JSE, Quraish N (1998) Self-monitoring dysfunction and the schizophrenic symptoms of alien control. Psychol Med 28:675–683CrossRefPubMedGoogle Scholar
  35. Strauss ME (1993) Relations of symptoms to cognitive deficits in schizophrenia. Schizophr Bull 19:215–231PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Richard S. E. Keefe
    • 1
  • Margaret P. Poe
    • 1
  • Joseph P. McEvoy
    • 1
  • Adam Vaughan
    • 1
  1. 1.Duke University Medical CenterDurhamUSA

Personalised recommendations